Literature DB >> 7889966

Antibacterial activity of sucralfate versus aluminum chloride in simulated gastric fluid.

L Welage1, P Carver, K Welch.   

Abstract

Studies have previously demonstrated that sucralfate possesses intrinsic antibacterial activity. This study was designed to indirectly assess whether aluminum is the active antibacterial component of sucralfate and to further evaluate factors that may influence this agent's antibacterial activity. Utilizing an in vitro model, the antibacterial activity of sucralfate, an equivalent quantity of aluminum in the form of aluminum chloride, and a control were compared. In addition, the influences of bacterial species (Enterobacter cloacae and Pseudomonas aeruginosa), time (0-24 h) and environmental pH (3,5,7) on the agents' antibacterial activities were evaluated. Equivalent quantities of aluminum, as either sucralfate or aluminum chloride, were added to two of three flasks containing approximately 10(5) cfu/ml of bacteria in pH-adjusted simulated gastric fluid. The third flask served as a control. Samples were obtained over 24 h, diluted and subcultured onto agar plates. The experiments demonstrated that bacterial growth was influenced by pH, time and treatment (aluminum chloride or sucralfate). Regardless of pH or bacterial species, bacterial death occurred within 20 min following the addition of aluminum chloride. In contrast, bacterial death following the addition of sucralfate was more variable and appeared to be pH dependent. In conclusion, sucralfate and aluminum chloride both possess antibacterial activity, even at pH values that normally support bacterial growth in gastric fluid. Although differences in the antibacterial activity of the two agents may in part be related to drug-induced changes in pH, these differences also support data suggesting that aluminum release from sucralfate is incomplete and is dependent on pH.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889966     DOI: 10.1007/bf02111825

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Gastroduodenal dysfunction as a cause of gastric bacterial overgrowth in patients undergoing mechanical ventilation of the lungs.

Authors:  T J Inglis; L J Sproat; M J Sherratt; P M Hawkey; J S Gibson; M V Shah
Journal:  Br J Anaesth       Date:  1992-05       Impact factor: 9.166

2.  Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway.

Authors:  G C du Moulin; D G Paterson; J Hedley-Whyte; A Lisbon
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

3.  Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung.

Authors:  T J Inglis; M J Sherratt; L J Sproat; J S Gibson; P M Hawkey
Journal:  Lancet       Date:  1993-04-10       Impact factor: 79.321

Review 4.  Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria.

Authors:  T J Foster
Journal:  Microbiol Rev       Date:  1983-09

5.  Development and characteristics of sucralfate.

Authors:  R Nagashima
Journal:  J Clin Gastroenterol       Date:  1981       Impact factor: 3.062

6.  Effects of gastric alkalization on bacterial colonization in critically ill patients.

Authors:  B M Garvey; J A McCambley; D V Tuxen
Journal:  Crit Care Med       Date:  1989-03       Impact factor: 7.598

7.  Antacid, sucralfate, and prostaglandin E2 effects on the growth and potential for translocation of Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus in an in vitro gastric simulation.

Authors:  M P Goeger; G K Dupuis; D N Herndon; M C Robson; J P Heggers
Journal:  J Burn Care Rehabil       Date:  1991 Jan-Feb

Review 8.  The gastropulmonary route of infection--fact or fiction?

Authors:  M Tryba
Journal:  Am J Med       Date:  1991-08-08       Impact factor: 4.965

9.  Binding and killing of bacteria by bismuth subsalicylate.

Authors:  T E Sox; C A Olson
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

10.  Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia.

Authors:  L F Martin; F V Booth; R G Karlstadt; J H Silverstein; D M Jacobs; J Hampsey; S C Bowman; C A D'Ambrosio; F W Rockhold
Journal:  Crit Care Med       Date:  1993-01       Impact factor: 7.598

View more
  1 in total

1.  Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials.

Authors:  Waleed Alhazzani; Fayez Alshamsi; Emilie Belley-Cote; Diane Heels-Ansdell; Romina Brignardello-Petersen; Mustafa Alquraini; Anders Perner; Morten Hylander Møller; Mette Krag; Saleh Almenawer; Bram Rochwerg; Joanna Dionne; Roman Jaeschke; Mohammed Alshahrani; Adam Deane; Dan Perri; Lehana Thebane; Awad Al-Omari; Simon Finfer; Deborah Cook; Gordon Guyatt
Journal:  Intensive Care Med       Date:  2017-12-04       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.